- 26 June 2022
Fluorescence microscopy traces Grubbs catalysts’ winding paths during polymerization.
- 16 June 2022
A thin layer of bridging molecules boosts performance by helping charge move seamlessly between layers in the device.
- 02 June 2022
GolR reductase might be harnessed to purify the precious metal from electronic waste.
- 17 May 2022
Latest study on droplets spontaneously forming hydrogen peroxide tackles ozone contamination questions.
- 29 April 2022
Nickel catalyst helps greenhouse gas prove its worth as a chemical reagent.
- 26 June 2022
TESTIMONIALS“As an editor and reporter, Mark Peplow is fast, accurate, and versatile. He covers science policy and pure research with equal passion, and his writing combines a scientist’s precision with a journalist’s verve.” Tim Appenzeller
Former Chief Magazine Editor at Nature, now News Editor at Science
"Mark guided me through some of the most challenging stories I've written. These are pieces I might not have attempted were it not for his steady editorial hand." Linda Nordling
Freelance Journalist, South Africa
“Working with Mark is never anything other than a pleasure. He is the kind of editor that writers hope for: able to identify what needs fixing and what doesn’t, bringing to bear a wealth of knowledge, always clear, prompt and easy to talk with. Much of that comes from being a splendid writer himself.”
Freelance Science Writer
Category Archives: My Work
The virtual world behind London’s Crossrail, for Spectrum magazine.
All the latest research on artemisinin, for Chemical & Engineering News.
Nature article explores how chemists are adapting to the glut of shale gas.
A profile of the BMJ’s editor, Fiona Godlee, for STAT magazine.
Exclusive news article for Nature about artemisinin.
Nature article about Swiss-cheese-like materials called metal–organic frameworks.
A Nature article about the effort to build a machine that can synthesize any organic compound.
A torrid tale of physics and showmanship, for Nautilus magazine.
Exclusive news story for Nature magazine.
Synthetic biology delivers combination therapies into an uncertain market.